Either through the courts or a postponement by the Trump administration itself, the Medicare Part B rule seems destined to remain dormant instead of going into effect in January as scheduled.
Health care policy experts Stacey Hughes, executive VP-designate of America's Health Insurance Plans, Foley Hoag partner Ross Margulies and BGR's Remy Brim discuss the fate of President Trump’s eleventh-hour drug pricing rules during the Biopharma Congress. • Source: Screenshot
